- Market Realist•21 minutes ago
Celgene (CELG) is exploring investigational drugs such as sotatercept and CC-486 (oral azacitidine) to treat patients suffering with various myeloid diseases.
- Investopedia•1 hour ago
The top 15 cancer drugs will account for a record $90 billion sales by 2022, according to a new study.
- Market Realist•2 hours ago
Data from Celgene's Phase 2 open-label long-term extension trial have shown that 61.0% of MDS patients achieved transfusion independence with luspatercept.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||111.62 x 500|
|Ask||111.66 x 300|
|Day's Range||111.26 - 112.99|
|52 Week Range||93.05 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||42.37|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|